John Jakubczak

3.1k citations

27 papers · 2.4k indexed · 1 hit paper · h-index 20

Molecular Biology top 5%
Plant Science top 2%
Genetics top 5%
Oncology top 10%
Cancer Research top 10%

Co-authors: Thomas H. Eickbush William D. Burke Yue Xiong Glenn Merlino Lalage M. Wakefield Diana C. Haines Erwin P. Böttinger Susan Garges
Topics: Virus-based gene therapy research (6 papers)Chromosomal and Genetic Variations (6 papers)Cancer Research and Treatments (5 papers)
Cited by: Plant Science Molecular Biology Genetics
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Czechia United Kingdom

In The Last Decade

John Jakubczak

27 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: A mechanism for non-LTR retrotransposition

1993 946 citations John Jakubczak, Thomas H. Eickbush et al. Cell profile →

Peers

Countries citing papers authored by John Jakubczak

Since Specialization

Citations

This map shows the geographic impact of John Jakubczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Jakubczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Jakubczak more than expected).

Fields of papers citing papers by John Jakubczak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Jakubczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Jakubczak. The network helps show where John Jakubczak may publish in the future.

Co-authorship network of co-authors of John Jakubczak

This figure shows the co-authorship network connecting the top 25 collaborators of John Jakubczak. A scholar is included among the top collaborators of John Jakubczak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Jakubczak. John Jakubczak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Analysis of the γ-Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia 2012 ·Molecular Cancer Therapeutics ·Jeremy B. Samon,Mireia Castillo-Martín,Michael Hadler,(unknown),Elisabeth Paietta,Janis Racevskis,Peter H. Wiernik,Jacob M. Rowe,John Jakubczak,Sophia Randolph,Carlos Cordon‐Cardo,Adolfo A. Ferrando	86
2	Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours 2011 ·European Journal of Cancer ·Patrick Schöffski,Suzanne F. Jones,Herlinde Dumez,Jeffrey R. Infante,(unknown),Camilla Fowst,Paola Gerletti,Huiping Xu,John Jakubczak,Patricia A. English,Kristen J. Pierce,Howard A. Burris	49
3	Reversal of glucocorticoid resistance by the g-secretase inhibitor PF-03084014 in T-cell acute lymphoblastic leukemia. 2011 ·Journal of Clinical Oncology ·Jeremy B. Samon,Mireia Castillo-Martín,John Jakubczak,Sophia Randolph,Carlos Cordon‐Cardo,Arny A. Ferrando	1
4	Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer 2004 ·Cancer Gene Therapy ·Patricia C. Ryan,John Jakubczak,David A. Stewart,Lynda K. Hawkins,Cheng Cheng,Lori Clarke,Shanthi Ganesh,Carl Hay,(unknown),Michele Kaloss,Anthony Marinov,Sandrina Phipps,P. Seshidhar Reddy,Pamela S. Shirley,(unknown),Ling Xu,Jingping Yang,Suzanne Forry‐Schaudies,Paul L. Hallenbeck	36
5	Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL 2004 ·Cancer Gene Therapy ·Kevin D. Burroughs,Dawn B. Kayda,Kiran Sakhuja,(unknown),John Jakubczak,J. Andrew Bristol,David L. Ennist,Paul L. Hallenbeck,Michael Kaleko,Sheila Connelly	8
6	Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis 2002 ·Proceedings of the National Academy of Sciences ·Shiquan Liu,Wenjing Liu,John Jakubczak,Gregory L. Erexson,Kenneth R. Tindall,Richard Chan,William J. Muller,Sankar Adhya,Susan Garges,Glenn Merlino	21
7	Adenovirus Type 5 Viral Particles Pseudotyped with Mutagenized Fiber Proteins Show Diminished Infectivity of Coxsackie B-Adenovirus Receptor-Bearing Cells 2001 ·Journal of Virology ·John Jakubczak,Michele L. Rollence,David A. Stewart,(unknown),Dan J. Von Seggern,Glen R. Nemerow,Susan C. Stevenson,Paul L. Hallenbeck	63
8	Enhanced Gene Transfer to Rabbit Jugular Veins by an Adenovirus Containing a Cyclic RGD Motif in the HI Loop of the Fiber Knob 2001 ·Journal of Vascular Research ·Carl Hay,Héctor De León,(unknown),John Jakubczak,(unknown),Paul L. Hallenbeck,Sharon K. Powell,Gene Liau,Susan C. Stevenson	26
9	Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis 2000 ·Molecular and Cellular Biology ·Toshiyuki Otsuka,John Jakubczak,Wilfred D. Vieira,Donald P. Bottaro,(unknown),William J. LaRochelle,Glenn Merlino	47
10	Antiangiogenic Gene Therapy for Cancer via Systemic Administration of Adenoviral Vectors Expressing Secretable Endostatin 2000 ·Human Gene Therapy ·(unknown),(unknown),Qin Li,Sandrina Phipps,John Jakubczak,David A. Stewart,(unknown),Suzanne Forry‐Schaudies,Jeanette M. Wood,Christian Schnell,Paul L. Hallenbeck	74
11	NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo 1998 ·Molecular and Cellular Biology ·John Jakubczak,William J. LaRochelle,Glenn Merlino	48
12	Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. 1997 ·PubMed ·Erwin P. Böttinger,John Jakubczak,Diana C. Haines,(unknown),Lalage M. Wakefield	156
13	Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. 1996 ·Proceedings of the National Academy of Sciences ·John Jakubczak,Glenn Merlino,John E. French,William J. Muller,(unknown),Sankar Adhya,Susan Garges	188
14	Increased Susceptibility to N‐Nitrosomethylurea Gastric Carcinogenesis in Transforming Growth Factor α Transgenic Mice with Gastric Hyperplasia 1995 ·Japanese Journal of Cancer Research ·Seiko Tamano,John Jakubczak,Hitoshi Takagi,Glenn Merlino,Jerrold M. Ward	11
15	Sequence relationship of retrotransposable elements R1 and R2 within and between divergent insect species. 1993 ·Molecular Biology and Evolution ·William D. Burke,Danna G. Eickbush,Yue Xiong,John Jakubczak,Thomas H. Eickbush	67
16	Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: A mechanism for non-LTR retrotranspositionbreakdown → 1993 ·Cell ·(unknown),(unknown),John Jakubczak,Thomas H. Eickbush	946
17	Turnover of R1 (type I) and R2 (type II) retrotransposable elements in the ribosomal DNA of Drosophila melanogaster. 1992 ·Genetics ·John Jakubczak,(unknown),R. C. Woodruff,Thomas H. Eickbush	73
18	Type I (R1) and type II (R2) ribosomal DNA insertions of Drosophila melanogaster are retrotransposable elements closely related to those of Bombyx mori 1990 ·Journal of Molecular Biology ·John Jakubczak,Yue Xiong,Thomas H. Eickbush	130
19	Ribosomal DNA insertion elements R1Bm and R2Bm can transpose in a sequence specific manner to locations outside the 28S genes 1988 ·Nucleic Acids Research ·Yue Xiong,William D. Burke,John Jakubczak,Thomas H. Eickbush	44
20	On the Causes of Monophagy in Drosophila quinaria 1988 ·Evolution ·Avis C. James,John Jakubczak,Michael P. Riley,John Jaenike	7

About John Jakubczak

John Jakubczak is a scholar working on Biotechnology, Hepatology and Oncology, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Chromosomal and Genetic Variations (6 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Plant Science (1.2k citations), Molecular Biology (1.9k citations) and Genetics (458 citations). John Jakubczak has collaborated with scholars based in United States, Czechia and United Kingdom. Frequent co-authors include Thomas H. Eickbush, William D. Burke, Yue Xiong, Glenn Merlino, Lalage M. Wakefield, Diana C. Haines, Erwin P. Böttinger, Susan Garges, William J. Muller and Sankar Adhya. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact